Literature DB >> 1597808

Trypanosoma cruzi in wild raccoons and opossums in North Carolina.

V Karsten1, C Davis, R Kuhn.   

Abstract

Trypanosoma cruzi was isolated from 1 of 12 (8.3%) opossums and 3 of 20 (15%) raccoons from the piedmont area of North Carolina. Although T. cruzi has been isolated previously from wild mammals in the southern United States, the present study is the first published report of naturally occurring T. cruzi infection of wild mammals in North Carolina. All 4 isolates were maintained successfully in axenic culture and in murine fibroblasts. In addition, intraperitoneal injection of 1 x 10(6) culture forms of 1 of the opossum isolates into C3H mice resulted in low but detectable parasitemias as early as day 6 of infection. These mice resolved parasitemia and survived infection. Intraperitoneal injection of 1 x 10(6) culture forms of a raccoon isolate resulted in the death of 3 out of 4 mice. Surprisingly, parasitemias were never detected in the peripheral blood of these mice. Infection of murine fibroblasts in vitro resulted in the presence of intracellular amastigote stages characteristic of T. cruzi.

Entities:  

Mesh:

Year:  1992        PMID: 1597808

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  12 in total

1.  Trypanosoma cruzi in non-human primates with a history of stillbirths: a retrospective study (Papio hamadryas spp.) and case report (Macaca fascicularis).

Authors:  Jessica L Grieves; Gene B Hubbard; Jeff T Williams; John L Vandeberg; Edward J Dick; Juan C López-Alvarenga; Natalia E Schlabritz-Loutsevitch
Journal:  J Med Primatol       Date:  2008-07-30       Impact factor: 0.667

2.  Infectivity, pathogenicity, and virulence of Trypanosoma cruzi Isolates from sylvatic animals and vectors, and domestic dogs from the United States in ICR strain mice and SD strain rats.

Authors:  Dawn M Roellig; Michael J Yabsley
Journal:  Am J Trop Med Hyg       Date:  2010-09       Impact factor: 2.345

3.  Seroprevalence of Trypanosoma cruzi among eleven potential reservoir species from six states across the southern United States.

Authors:  Emily L Brown; Dawn M Roellig; Matthew E Gompper; Ryan J Monello; Krista M Wenning; Mourad W Gabriel; Michael J Yabsley
Journal:  Vector Borne Zoonotic Dis       Date:  2009-12-18       Impact factor: 2.133

Review 4.  Trypanosoma cruzi and Chagas' Disease in the United States.

Authors:  Caryn Bern; Sonia Kjos; Michael J Yabsley; Susan P Montgomery
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

5.  Lack of Trypanosoma cruzi Infection in Urban Roof Rats (Rattus rattus) at a Texas Facility Housing Naturally Infected Nonhuman Primates.

Authors:  Carolyn L Hodo; Nicole R Bertolini; John C Bernal; John L VandeBerg; Sarah A Hamer
Journal:  J Am Assoc Lab Anim Sci       Date:  2017-01-01       Impact factor: 1.232

6.  Estimating contact process saturation in sylvatic transmission of Trypanosoma cruzi in the United States.

Authors:  Christopher Kribs-Zaleta
Journal:  PLoS Negl Trop Dis       Date:  2010-04-27

7.  Fatal acute Chagas disease in a chimpanzee.

Authors:  Yugendar R Bommineni; Edward J Dick; J Scot Estep; John L Van de Berg; Gene B Hubbard
Journal:  J Med Primatol       Date:  2009-03-05       Impact factor: 0.667

8.  Combined use of enzyme-linked immunosorbent assay and flow cytometry to detect antibodies to Trypanosoma cruzi in domestic canines in Texas.

Authors:  Sean V Shadomy; Stephen C Waring; Olindo Assis Martins-Filho; Rodrigo Corrêa Oliveira; Cynthia L Chappell
Journal:  Clin Diagn Lab Immunol       Date:  2004-03

9.  Evaluation of the Chagas Stat-Pak assay for detection of Trypanosoma cruzi antibodies in wildlife reservoirs.

Authors:  Michael J Yabsley; Emily L Brown; Dawn M Roellig
Journal:  J Parasitol       Date:  2009-06       Impact factor: 1.276

Review 10.  Kissing bugs in the United States: risk for vector-borne disease in humans.

Authors:  Stephen A Klotz; Patricia L Dorn; Mark Mosbacher; Justin O Schmidt
Journal:  Environ Health Insights       Date:  2014-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.